To evaluate the prognostic potential for KLF6 expression in PAAD, we analyzed clinical specimens by IHC and found that the KLF6 immunostained signals in the PAAD tissue were markedly different among samples (Figure 1E). The gene discussed is KLF6; the disease is pancreatic adenocarcinoma.